| Original language | English |
|---|---|
| Pages (from-to) | 919-921 |
| Number of pages | 3 |
| Journal | Clinical Chemistry |
| Volume | 57 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2011 |
Primer sequence disclosure: A clarification of the MIQE guidelines
Stephen A. Bustin, Vladimir Benes, Jeremy A. Garson, Jan Hellemans, Jim Huggett, Mikael Kubista, Reinhold Mueller, Tania Nolan, Michael W. Pfaffl, Gregory L. Shipley, Jo Vandesompele, Carl T. Wittwer
- Barts and The London School of Medicine and Dentistry
- European Molecular Biology Laboratory Heidelberg
- Royal Free and University College Medical School
- Ghent University Hospital
- Biogazelle NV
- LGC Ltd.
- University College London
- TATAA Biocenter
- Institute of Biotechnology of the Academy of Sciences of the Czech Republic
- Sequenom, Inc.
- Sigma-Aldrich
- University of Texas Health Science Center at Houston
- University of Utah School of Medicine
- ARUP Institute for Clinical and Experimental Pathology
Research output: Contribution to journal › Letter › peer-review
63
Scopus
citations